Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals Market Cap : 144.97M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 144.97M |
| November 19, 2026 | 154.74M |
| November 18, 2026 | 165.33M |
| November 17, 2026 | 161.26M |
| November 16, 2026 | 160.44M |
| November 13, 2026 | 172.25M |
| November 12, 2026 | 192.61M |
| November 11, 2026 | 217.45M |
| November 10, 2026 | 224.78M |
| November 09, 2026 | 232.16M |
| November 06, 2026 | 210.72M |
| November 05, 2026 | 198.99M |
| November 04, 2026 | 218.41M |
| November 03, 2026 | 211.94M |
| November 02, 2026 | 211.94M |
| October 30, 2026 | 224.07M |
| October 29, 2026 | 245.91M |
| October 28, 2026 | 223.26M |
| October 27, 2026 | 194.95M |
| October 26, 2026 | 178.77M |
| October 23, 2026 | 186.05M |
| October 22, 2026 | 186.05M |
| October 21, 2026 | 182.81M |
| October 20, 2026 | 182.41M |
| October 19, 2026 | 174.73M |
| Date | Value |
|---|---|
| October 16, 2026 | 172.30M |
| October 15, 2026 | 183.62M |
| October 14, 2026 | 182.01M |
| October 13, 2026 | 189.29M |
| October 12, 2026 | 197.38M |
| October 09, 2026 | 200.61M |
| October 08, 2026 | 195.76M |
| October 07, 2026 | 195.76M |
| October 06, 2026 | 198.18M |
| October 05, 2026 | 202.23M |
| October 02, 2026 | 201.42M |
| October 01, 2026 | 196.97M |
| September 30, 2026 | 204.66M |
| September 29, 2026 | 202.23M |
| September 28, 2026 | 213.55M |
| September 25, 2026 | 214.36M |
| September 24, 2026 | 216.79M |
| September 23, 2026 | 220.02M |
| September 22, 2026 | 233.78M |
| September 21, 2026 | 217.60M |
| September 18, 2026 | 211.94M |
| September 17, 2026 | 214.36M |
| September 16, 2026 | 215.98M |
| September 15, 2026 | 219.22M |
| September 14, 2026 | 224.07M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.956B |
| Alnylam Pharmaceuticals, Inc. | 19.25B |
| Anika Therapeutics, Inc. | 177.20M |
| Savara, Inc. | 875.58M |
| Arrowhead Pharmaceuticals, Inc. | 5.845B |
Market Cap Related Metrics
| Price to Book Value | 4.707 |
| Price | 1.78 |
| Earnings Yield | -44.85% |